Hoth Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -4 | |||
EBITDA | -4,105 | -2,199 | -3,476 | -2,383 |
EBIT | -3,480 | |||
Net Income | -4,105 | -2,199 | -3,475 | -2,382 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,492 | -2,372 | -2,788 | -2,028 |
Cash | 7,847 | 9,014 | 11,317 | 7,038 |
Basic Shares | 13,787 | 13,180 | 9,777 | 7,290 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -66 | -46,871 | ||
EBITDA | 27 | -153 | -10,678 | -14,313 |
EBIT | -8,188 | -7,845 | -21,744 | -14,101 |
Net Income | -8,188 | -7,845 | -11,371 | -14,313 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,978 | -8,447 | -9,371 | -12,207 |
Cash | 7,038 | 9,292 | 6,428 | 8,538 |
Basic Shares | 6,375 | 3,409 | 1,197 | 893 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.30 |
2025-06-30 | -$0.17 |
2025-03-31 | -$0.27 |
2024-12-31 | -$0.32 |
